HFG
ABBV icon

Heron Financial Group’s AbbVie ABBV Stock Holding History

Heron Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,298
Closed -$207K – 143
2023
Q1 		$207K Hold
1,298
– – 0.11% 139
2022
Q4 		$212K Buy
+1,298
New +$199K 0.14% 123
2022
Q3 		– Sell
-1,335
Closed -$204K – 133
2022
Q2 		$204K Hold
1,335
– – 0.12% 130
2022
Q1 		$216K Buy
+1,335
New +$194K 0.11% 142
2020
Q1 		– Sell
-2,275
Closed -$218K – 110
2019
Q4 		$218K Buy
+2,275
New +$189K 0.18% 119

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Heron Financial Group's ABBV Position: Q2 2023 in Review

Heron Financial Group sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 1,298 shares — an estimated $207K sold.

Heron Financial Group first reported a position in ABBV in Q4 2019 and held it in 5 quarters. The position peaked at $218K in Q4 2019. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Heron Financial Group reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Heron Financial Group sold 1,298 AbbVie shares in Q2 2023, an estimated $207K.
  • Heron Financial Group first reported a position in AbbVie in Q4 2019 and held it in 5 quarters.
  • Heron Financial Group's AbbVie position peaked at $218K in Q4 2019.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Heron Financial Group's 13F filing for Q2 2023, filed 10 Aug 2023.